Scientist/Senior Scientist to join Biotechnology Downstream Development in our API R&D facilities in Oslo

We are looking for a new colleague to join our Biotechnology Downstream Development team in Xellia’s API R&D facilities in Oslo.

In this role, you will contribute to the development and optimization of purification processes for the production of life-saving antibiotics.

Xellia API R&D consists of approx. 50 employees across departments located in Oslo, Copenhagen, and Budapest. In Oslo, we have three departments in modern office and laboratory facilities. We are now seeking a Scientist/Senior Scientist to strengthen our Biotechnology Downstream Development department.

Your new team

Biotechnology Downstream Development is responsible for developing purification processes for new Active Pharmaceutical Ingredients (APIs) as well as improving processes for existing APIs, including scale-up and technology transfer to production sites.

The department works with a wide range of purification technologies, including chromatography, filtration, crystallization/precipitation, extraction, and drying. We are currently seven employees based in Oslo, working in an international R&D environment across both functional lines and cross-functional project teams.

Room for development and responsibility

At Xellia, every single colleague counts. As a small company, we are good at making room for the individual. If you seek out development, knowledge or more responsibility, you will rarely get no and it gives you the opportunity to dive into your area. Because we know that the belief in talent combined with the desire to grow is the recipe for growth. Both for you and for us. 

Your role and responsibilities

• Develop scalable and reproducible purification processes for new and existing APIs (fermentation-based and semi-synthetic)

• Design, perform, and evaluate experiments in collaboration with scientists and engineers

• Document results with full traceability according to internal procedures

  Profile and Skills 

• M.Sc. in Chemical Engineering, Biotechnology, Biochemistry, Process Technology, or similar

• Solid knowledge of purification technologies (chromatography, crystallization, filtration, extraction, drying)

• Hands-on experience from bioprocess development/production in pharma or fine chemicals (graduates also welcome)

• Practical lab skills with an analytical mindset and problem-solving abilities

• Efficient, flexible, and motivated team player

• Fluent in English and Norwegian/Scandinavian (written and spoken)

Are we your new colleagues?
Please send your application no later than September 15. We will be reviewing applications and interviewing candidates on an ongoing basis, so we encourage you to apply as soon as possible.

If you have any questions, please reach out to Senior Manager Biotechnology Downstream Development, Sissel Hauge, at +47 901 53 248.

Xellia Pharmaceuticals is a specialty pharmaceutical company and a global leader in providing anti-infective treatments and other critical care therapies for serious and often life-threatening conditions. Xellia has an extensive heritage in developing, manufacturing, and commercializing anti-infective products.

Headquartered in Copenhagen, Denmark, and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1400 employees globally, including state-of-the-art manufacturing sites in China, Denmark, and Hungary. Our strong market position is built on more than 120 years of pharmaceutical industry experience.

Further information about Xellia can be found at: www.xellia.com
Connect with us on LinkedIn